Aleta Biotherapeutics is a startup based in the United States, 3 tracked investors.
Aleta Biotherapeutics is a startup founded in 2016 based in the United States. Brouky records 3 investors associated with the company.
Aleta Biotherapeutics develops novel CAR T engager proteins designed to improve the efficacy of CAR T cell therapies in treating cancers such as lymphoma, myeloma, and acute myeloid leukemia.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.